Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celine Lee

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The British Journal of Ophthalmology|June 17, 2026
Real-World Insights on Switching Aflibercept Dosage for Enhanced Outcomes in Retinal Vein Occlusion (RISE-RVO): visual, anatomical and durability outcomesChi Tuyet Nguyen, Rasmus Klock Bøgh Lassen, Mads Odgaard Mæng, et al.
Retina (Philadelphia, Pa.)|May 26, 2026
Real-World Outcomes after Switch to Aflibercept 8 mg in Neovascular AMD: Twelve Months Follow-up on 654 EyesCeline Lee, Mary Graciya Karunainathan, Kaweh Daniel Zohalinejad, et al.
Acta Ophthalmologica|May 27, 2026
Real-world insights on switching aflibercept dosage for enhanced outcomes in age-related macular degeneration (RISE-AMD): Safety dataMary Graciya Karunainathan, Celine Lee, Kaweh Daniel Zohalinejad, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The British Journal of Ophthalmology|June 17, 2026
Real-World Insights on Switching Aflibercept Dosage for Enhanced Outcomes in Retinal Vein Occlusion (RISE-RVO): visual, anatomical and durability outcomesChi Tuyet Nguyen, Rasmus Klock Bøgh Lassen, Mads Odgaard Mæng, et al.
Retina (Philadelphia, Pa.)|May 26, 2026
Real-World Outcomes after Switch to Aflibercept 8 mg in Neovascular AMD: Twelve Months Follow-up on 654 EyesCeline Lee, Mary Graciya Karunainathan, Kaweh Daniel Zohalinejad, et al.
Acta Ophthalmologica|May 27, 2026
Real-world insights on switching aflibercept dosage for enhanced outcomes in age-related macular degeneration (RISE-AMD): Safety dataMary Graciya Karunainathan, Celine Lee, Kaweh Daniel Zohalinejad, et al.
Pageof 2